Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.

Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan B, Karydas A, Baker MC, DeJesus-Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE, Seeley W, Miller BL, Boxer AL.

Neurology. 2012 Sep 4;79(10):1002-11. doi: 10.1212/WNL.0b013e318268452e. Epub 2012 Aug 8.

PMID:
22875087
2.

[Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].

Lillo P, Matamala JM, Valenzuela D, Verdugo R, Castillo JL, Ibáñez A, Slachevsky A.

Rev Med Chil. 2014 Jul;142(7):867-79. doi: 10.4067/S0034-98872014000700007. Review. Spanish.

PMID:
25378006
3.

How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?

van Blitterswijk M, DeJesus-Hernandez M, Rademakers R.

Curr Opin Neurol. 2012 Dec;25(6):689-700. doi: 10.1097/WCO.0b013e32835a3efb. Review.

PMID:
23160421
4.

Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.

Verma A.

Neurol India. 2014 Jul-Aug;62(4):347-51. doi: 10.4103/0028-3886.141174. Review.

PMID:
25237937
5.

The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.

Gascon E, Gao FB.

J Neurogenet. 2014 Mar-Jun;28(1-2):30-40. doi: 10.3109/01677063.2013.876021. Epub 2014 Feb 10. Review.

PMID:
24506814
6.

C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.

Rohrer JD, Isaacs AM, Mizielinska S, Mead S, Lashley T, Wray S, Sidle K, Fratta P, Orrell RW, Hardy J, Holton J, Revesz T, Rossor MN, Warren JD.

Lancet Neurol. 2015 Mar;14(3):291-301. doi: 10.1016/S1474-4422(14)70233-9. Epub 2015 Jan 29. Review. Erratum in: Lancet Neurol. 2015 Apr;14(4):350.

PMID:
25638642
7.

The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.

Cooper-Knock J, Shaw PJ, Kirby J.

Acta Neuropathol. 2014 Mar;127(3):333-45. doi: 10.1007/s00401-014-1251-9. Epub 2014 Feb 4. Review.

PMID:
24493408
8.

[Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].

Gjerde KV, Tysnes OB.

Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):302-6. doi: 10.4045/tidsskr.13.0049. Review. Norwegian.

PMID:
24518478
9.

C9ORF72 mutations in neurodegenerative diseases.

Liu Y, Yu JT, Zong Y, Zhou J, Tan L.

Mol Neurobiol. 2014 Feb;49(1):386-98. doi: 10.1007/s12035-013-8528-1. Epub 2013 Aug 10. Review.

PMID:
23934648
10.

Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.

Stepto A, Gallo JM, Shaw CE, Hirth F.

Acta Neuropathol. 2014 Mar;127(3):377-89. doi: 10.1007/s00401-013-1235-1. Epub 2013 Dec 24. Review.

PMID:
24366528
11.

Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations.

Floris G, Borghero G, Cannas A, Di Stefano F, Murru MR, Corongiu D, Cuccu S, Tranquilli S, Cherchi MV, Serra A, Loi G, Marrosu MG, Chiò A, Marrosu F.

J Neurol. 2015 Feb;262(2):375-84. doi: 10.1007/s00415-014-7575-5. Epub 2014 Nov 20. Review.

PMID:
25408367
12.

Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Patel AN, Sampson JB.

Curr Neurol Neurosci Rep. 2015 Sep;15(9):59. doi: 10.1007/s11910-015-0582-9. Review.

PMID:
26198888
13.

Biomarker development for C9orf72 repeat expansion in ALS.

Mendez EF, Sattler R.

Brain Res. 2015 May 14;1607:26-35. doi: 10.1016/j.brainres.2014.09.041. Epub 2014 Sep 27. Review.

PMID:
25261695
14.

C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Cruts M, Engelborghs S, van der Zee J, Van Broeckhoven C.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016.
2015 Jan 8.

PMID:
25577942
Free Books & Documents
15.

Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS.

Kumar V, Kashav T, Islam A, Ahmad F, Hassan MI.

Neurochem Int. 2016 Aug 15. pii: S0197-0186(16)30155-3. doi: 10.1016/j.neuint.2016.08.008. [Epub ahead of print] Review.

PMID:
27539655
16.

Frontotemporal dementia.

Perry DC, Miller BL.

Semin Neurol. 2013 Sep;33(4):336-41. doi: 10.1055/s-0033-1359316. Epub 2013 Nov 14. Review.

PMID:
24234354
17.

C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Yokoyama JS, Sirkis DW, Miller BL.

Am J Neurodegener Dis. 2014 Mar 28;3(1):1-18. eCollection 2014. Review.

PMID:
24753999
18.

Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.

Todd TW, Petrucelli L.

J Neurochem. 2016 Aug;138 Suppl 1:145-62. doi: 10.1111/jnc.13623. Epub 2016 Jun 15. Review.

PMID:
27016280
19.

Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective.

Fernandes SA, Douglas AG, Varela MA, Wood MJ, Aoki Y.

J Nucleic Acids. 2013;2013:208245. doi: 10.1155/2013/208245. Epub 2013 Nov 17. Review.

PMID:
24349764
20.

[The pathogenesis of amyotrophic lateral sclerosis and frontal lobe dementia is unraveling: pathology of the nucleus and glutamate sensitivity].

Tienari P, Kiviharju A, Valori M, Lindholm D, Laaksovirta H.

Duodecim. 2016;132(5):423-31. Review. Finnish.

PMID:
27089615
Items per page

Supplemental Content

Write to the Help Desk